June 30,
2023

December 31,
2022

Accrued pre-clinical and clinical costs

$

2,694,611

$

2,137,317

Accrued product development costs

758,699

247,500

Accrued compensation

1,570,376

2,224,951

Accrued administrative costs

282,846

473,376

Accrued interest

1,112,271

916,108

Total

$

6,418,803

$

5,999,252